Literature DB >> 21959040

Biochemical characterization of the very long-chain fatty acid elongase ELOVL7.

Tatsuro Naganuma1, Yuichiro Sato, Takayuki Sassa, Yusuke Ohno, Akio Kihara.   

Abstract

Very long-chain fatty acids (VLCFAs) have a variety of physiological functions and are related to numerous disorders. The key step of VLCFA elongation is catalyzed by members of the elongase family, ELOVLs. Mammals have seven ELOVLs (ELOVL1-7), yet none of them has been purified and analyzed. In the presented study we purified ELOVL7 and measured its activity by reconstituting it into proteoliposomes. Purified ELOVL7 exhibited high activity toward acyl-CoAs with C18 carbon chain length. The calculated K(m) values toward C18:3(n-3)-CoA and malonyl-CoA were both in the μM range. We also found that progression of the VLCFA cycle enhances ELOVL7 activity.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959040     DOI: 10.1016/j.febslet.2011.09.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction.

Authors:  Christian Marsching; Mariona Rabionet; Daniel Mathow; Richard Jennemann; Christiane Kremser; Stefan Porubsky; Christian Bolenz; Klaus Willecke; Hermann-Josef Gröne; Carsten Hopf; Roger Sandhoff
Journal:  J Lipid Res       Date:  2014-09-29       Impact factor: 5.922

Review 3.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 4.  Lipids and prostate cancer.

Authors:  Janel Suburu; Yong Q Chen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-05       Impact factor: 3.072

5.  Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.

Authors:  Takayuki Sassa; Takeshi Wakashima; Yusuke Ohno; Akio Kihara
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

6.  The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways.

Authors:  Megumi Sawai; Yukiko Uchida; Yusuke Ohno; Masatoshi Miyamoto; Chieko Nishioka; Shigeyoshi Itohara; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2017-08-07       Impact factor: 5.157

7.  The elongation of very long-chain fatty acid 6 gene product catalyses elongation of n-13 : 0 and n-15 : 0 odd-chain SFA in human cells.

Authors:  Zhen Wang; Dong Hao Wang; Yuliya Goykhman; Yuanyuan Yan; Peter Lawrence; Kumar S D Kothapalli; J Thomas Brenna
Journal:  Br J Nutr       Date:  2019-01-03       Impact factor: 3.718

8.  Palmitoleic (16:1 cis-9) and cis-vaccenic (18:1 cis-11) acid alter lipogenesis in bovine adipocyte cultures.

Authors:  T A Burns; A K G Kadegowda; S K Duckett; S L Pratt; T C Jenkins
Journal:  Lipids       Date:  2012-10-18       Impact factor: 1.880

9.  Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.

Authors:  Sreemathi Logan; Martin-Paul Agbaga; Michael D Chan; Nabila Kabir; Nawajes A Mandal; Richard S Brush; Robert E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

10.  De novo transcriptomic analysis of gonad of Strongylocentrotus nudus and gene discovery for biosynthesis of polyunsaturated fatty acids.

Authors:  Zhenlin Wei; Xiaolin Liu; Zunchun Zhou; Junxiao Xu
Journal:  Genes Genomics       Date:  2019-03-04       Impact factor: 1.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.